Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study

OBJECTIVE: To evaluate the safety and efficacy of belimumab as adjunctive therapy to maintain remission in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). METHODS: In this multicenter, double‐blind, placebo‐controlled study, patients with AAV (ages ≥18 years) were randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayne, David, Blockmans, Daniel, Luqmani, Raashid, Moiseev, Sergey, Ji, Beulah, Green, Yulia, Hall, Leanne, Roth, David, Henderson, Robert B., Merkel, Peter A., Lozano, Jose Alfaro, Becker, Heidemarie, Quiroz, Armando Calvo, Carette, Simon, Carrillo‐Vazquez, Sandra, Cid, María C., D'Cruz, David, Deodhar, Atul, Flossman, Oliver, Garibotto, Giacomo, Gesualdo, Loreto, Hall, Stephen, Hauser, Thomas, Hellmich, Bernhard, Kidder, Dana, Kimmel, Martin, Little, Mark, Majdan, Maria, Maksimowicz‐McKinnon, Kathleen, Marder, Galina, Matsievskaia, Galina, Meneses, Ariel Salinas, Molloy, Eamonn, Mueller, Ruediger, Neuwelt, Clark, Hernandez, Jorge Ravelo, Specks, Ulrich, Tesar, Vladimir, Walsh, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Vasculitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593987/
https://www.ncbi.nlm.nih.gov/pubmed/30666823
http://dx.doi.org/10.1002/art.40802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593987/
https://www.ncbi.nlm.nih.gov/pubmed/30666823
http://dx.doi.org/10.1002/art.40802

Ejemplares similares